Science Current Events | Science News | Brightsurf.com
 

Rare Disease in Amish Children Sheds Light on Common Neurological Disorders, Penn Study Shows

May 12, 2010
PHILADELPHIA - So often the rare informs the common. Penn researchers investigating a regulatory protein involved in a rare genetic disease have shown that it may be related to epileptic and autistic symptoms in other more common neurological disorders.

A team of researchers from the University of Pennsylvania School of Medicine, led by Peter B. Crino, MD, PhD, associate professor of Neurology and director of the Penn Epilepsy Center, demonstrate how mutations in the STRAD-alpha gene can cause a disease called PMSE (polyhydramnios, megalencephaly, and symptomatic epilepsy) syndrome, found in a handful of Amish children. PMSE is characterized by an abnormally large brain, cognitive disability, and severe, treatment-resistant epilepsy.

Specifically, in an animal model, they found that the lack of the STRAD-alpha protein due to genetic mutations causes activation of the signaling pathway involving another protein called mTOR. In humans, this in turn may promote abnormal cell growth and cognitive problems in the developing brains of children. STRAD-alpha and mTOR proteins are part of a complex molecular network implicated in other, more common neurological disorders, many of which have autism-like symptoms as a component.

"The identification of a new gene that regulates mTOR provides fascinating insights into how mTOR pathway dysfunction may be associated with neurological disorders," says Crino. "Each new mTOR regulatory protein that is identified provides a new possible therapeutic target for drug development and treatment."

The research on PMSE - published this month in the Journal of Clinical Investigation - reveals clues about more common neurological disorders characterized by benign tumors and malformations of the brain, the most common of which is tuberous sclerosis complex (TSC). The root cause of TSC also lies in mutations in proteins along the mTOR pathway, however a different protein is affected compared to PMSE.

"It is quite compelling that TSC, a relatively common disorder, and PMSE, a rare disorder, are linked by a common cellular pathway, and exhibit similar severe neurological features," notes Crino. "In our study, we found that we could reverse some of the cellular features that result from STRAD-alpha deficiency in cell culture models of PMSE. This provides important conceptual support for more widespread treatment approaches that modify mTOR signaling in neurological disorders associated with epilepsy, autism, and cognitive disability."

Current estimates place tuberous sclerosis complex-affected births at one in 6,000. Nearly 1 million people worldwide are known to have TSC, with approximately 50,000 in the United States.

PMSE, on the other had, has only been described in 25 people in Lancaster County, PA. It's incidence among other Amish populations, let alone the rest of the country, is unknown. PMSE is also known as pretzel syndrome in the Amish community, because the lax joints of patients fold over easily. PMSE was identified in an Amish, or Old Order Mennonite pediatric population in 2007 by researchers from Penn and the Clinic for Special Children in Lancaster, PA, a genetic clinic devoted to the needs of the Amish.

The mTOR pathway normally controls cell growth, but in PMSE uncontrolled mTOR signaling leads to increases in brain size and areas in which the cerebral cortex is malformed. To prove this, the researchers knocked down the activity of the STRAD-alpha protein in a mouse model and caused malformations of the developing brain. The structure of these malformations was similar to what is seen in human PMSE and TSC and supports the conclusion that normal brain development in part depends on normal STRAD-alpha function. Localized brain malformations are among the most common causes of epilepsy and neurological disability in children.

This research was funded by the National Institute of Neurological Diseases and Stroke.

Ksenia Orlova, PhD, a graduate student in the Crino lab and Kevin Strauss, MD, Medical Director at the Clinic for Special Children, were also co-authors on the JCI paper.

Penn Medicine


Related Neurological Disorders Current Events and Neurological Disorders News Articles


Cancer drugs block dementia-linked brain inflammation, UCI study finds
A class of drugs developed to treat immune-related conditions and cancer - including one currently in clinical trials for glioblastoma and other tumors - eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to UC Irvine researchers.

Eavesdropping on brain cell chatter
Everything we do - all of our movements, thoughts and feelings - are the result of neurons talking with one another, and recent studies have suggested that some of the conversations might not be all that private.

Casual marijuana use linked to brain abnormalities in students
Young adults who used marijuana only recreationally showed significant abnormalities in two key brain regions that are important in emotion and motivation, scientists report.

UCI study finds modified stem cells offer potential pathway to treat Alzheimer's disease
UC Irvine neurobiologists have found that genetically modified neural stem cells show positive results when transplanted into the brains of mice with the symptoms and pathology of Alzheimer's disease.

TGen study identifies growth factor receptors that may prompt the spread of lung cancer
Preventing lung cancers from metastasizing to other parts of the body could provide benefit for patients against the leading cause of cancer death.

Amino acid fingerprints revealed in new study
Some three billion base pairs make up the human genome-the floor plan of life. In 2003, the Human Genome Project announced the successful decryption of this code, a tour de force that continues to supply a stream of insights relevant to human health and disease.

Vascular changes caused by deep brain stimulation using brain MRI
Deep brain stimulation has been widely used to treat patients with movement disorders and increasing attention has been paid to its use in the treatment of neurological and psychiatric disorders.

Fruitfly study: Epilepsy drug target implications for sleep disruption in brain disorders
A new study in a mutant fruitfly called sleepless (sss) confirmed that the enzyme GABA transaminase, which is the target of some epilepsy drugs, contributes to sleep loss.

Penn Medicine points to new ways to prevent relapse in cocaine-addicted patients
Relapse is the most painful and expensive feature of drug addiction-even after addicted individuals have been drug-free for months or years, the likelihood of sliding back into the habit remains high.

A new approach to Huntington's disease?
Tweaking a specific cell type's ability to absorb potassium in the brain improved walking and prolonged survival in a mouse model of Huntington's disease.
More Neurological Disorders Current Events and Neurological Disorders News Articles

Disconnected Kids: The Groundbreaking Brain Balance Program for Children with Autism, ADHD, Dyslexia, and Other Neurological Disorders

Disconnected Kids: The Groundbreaking Brain Balance Program for Children with Autism, ADHD, Dyslexia, and Other Neurological Disorders
by Dr. Robert Melillo (Author)


The proven, drug-free program to treat the cause-not just the symptoms-of autism spectrum disorders and related conditions.

Each year, an estimated 1.5 million children-one out of every six-are diagnosed with autism, Asperger's syndrome, ADHD, dyslexia, and obsessive compulsive disorder. Dr. Robert Melillo brings a fundamentally new understanding to the cause of these conditions with his revolutionary Brain Balance Program(tm). It has achieved real, fully documented results that have dramatically improved the quality of life for children and their families in every aspect: behavioral, emotional, academic, and social. Disconnected Kids shows parents how to use this drug-free approach at home, including:

?Fully customizable exercises that target physical, sensory, and...

Neurological Disorders due to Systemic Disease

Neurological Disorders due to Systemic Disease
by Steven L. Lewis (Editor)


Edited by
Steven L Lewis, MD, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USAHow do you identify which neurologic syndromes occur due to systemic disease?  Neurological problems commonly occur in the context of underlying systemic disease, and may even be the presenting symptom of a medical condition that has not yet been diagnosed. Consequently neurologists need to be aware when a neurological presentation might indicate an underlying systemic disorder.Neurological Disorders due to Systemic Disease provides the tools you need to make these connections. The unique neurologic presentation-based approach relates to the common clinical situations you encounter, including: HeadacheStrokeMovement disordersNeuromuscular...

Amazing Brain - Neurological Disorders

Amazing Brain - Neurological Disorders
by Connie Goldsmith (Author)


The Amazing Brain series offers exciting answers about how our brain works and why we respond to the world the way we do. Questions addressed in this 4-vol. set include: Do male and female brains work differently? Can music enhance learning and boost brain development? Was Einstein's brain more unique than the average brain? What dependencies are really true addictions? Can brain cells regenerate? ...

Metabotropic Glutamate Receptors: Molecular Mechanisms, Role in Neurological Disorders and Pharmacological Effects (Neuroscience Research Progress)

Metabotropic Glutamate Receptors: Molecular Mechanisms, Role in Neurological Disorders and Pharmacological Effects (Neuroscience Research Progress)
by M. Foster Olive (Editor)




The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders

The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders
by Elaine A. Moore (Author), Dr. Yash P. Agrawal (Foreword), Samantha Wilkinson (Foreword)


Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors...

Neurological Disorders in Famous Artists (Frontiers of Neurology and Neuroscience)

Neurological Disorders in Famous Artists (Frontiers of Neurology and Neuroscience)
by J. Bogousslavsky (Editor), M. G. Hennerici (Editor), H. Bazner (Editor), C. Bassetti (Editor)


The third part of "Neurological Disorders in Famous Artists" presents painters, musicians, and writers who had to fight against an acute or chronic neurological disease. Sometimes this fight was without success (e.g. Shostakovich, Schumann, Wolf, Pascal), but often a dynamic and paradoxical creativity of the clinical disorder was integrated into their artistic production (e.g. Klee, Ramuz). Occasionally, some even wrote the first report of a medical condition they observed in themselves, like Stendhal who made a detailed report of aphasic transient ischemic attacks before dying of stroke shortly thereafter. In rarer instances, a neurological disease was inaccurately attributed to an artist in order to explain certain features of his work (de Chirico, Schiele). Some chapters in this...

Driven to Distraction (Revised): Recognizing and Coping with Attention Deficit Disorder

Driven to Distraction (Revised): Recognizing and Coping with Attention Deficit Disorder
by Edward M. Hallowell M.D. (Author), John J. Ratey M.D. (Author)


Groundbreaking and comprehensive, Driven to Distraction has been a lifeline to the approximately eighteen million Americans who are thought to have ADHD. Now the bestselling book is revised and updated with current medical information for a new generation searching for answers.
 
Through vivid stories and case histories of patients—both adults and children—Hallowell and Ratey explore the varied forms ADHD takes, from hyperactivity to daydreaming. They dispel common myths, offer helpful coping tools, and give a thorough accounting of all treatment options as well as tips for dealing with a diagnosed child, partner, or family member. But most importantly, they focus on the positives that can come with this “disorder”—including high energy, intuitiveness, creativity, and...

Neuropsychological Neurology: The Neurocognitive Impairments of Neurological Disorders

Neuropsychological Neurology: The Neurocognitive Impairments of Neurological Disorders
by A. J. Larner (Author)


Understanding the cognitive aspects of neurological disorders is essential to manage effectively patients suffering from these conditions. This book begins by outlining the various cognitive domains and how these can be tested, before covering in depth the cognitive deficits seen in prototypical neurodegenerative cognitive disorders, (Alzheimer's disease, frontotemporal dementias, Huntington's disease, prionoses), and other common neurological disorders that may be complicated by cognitive impairment (stroke, multiple sclerosis, Parkinson's disease, brain tumours). This Second Edition has been completely revised and updated, with new material added throughout, including two new chapters: Sleep-Related Disorders, and Psychiatric Disorders in the Cognitive Function Clinic. This an...

Introduction to Neurogenic Communication Disorders, 7e

Introduction to Neurogenic Communication Disorders, 7e
by Robert H. Brookshire (Author)


This popular, well-respected textbook provides the most comprehensive and cutting-edge information on the foundations, diagnosis, assessment, management, and treatment of patients with neurogenic communication disorders. Still the only text on the market that surveys the entire range of disorders in a single volume, this new edition is completely up to date with the most current research and developments in the field. New coverage includes three new assessment chapters and new discussions of hot topics such as the functional, environmental, and social elements of communication. The book is supplemented throughout with engaging artwork, clinical tips, and practical advice featuring many examples from clinical settings.Colored boxes offer related facts and tips interspersed throughout the...

The Way to A: Empowering Children with Autism Spectrum and Other Neurological Disorders to Monitor and Replace Aggression and Tantrum Behavior

The Way to A: Empowering Children with Autism Spectrum and Other Neurological Disorders to Monitor and Replace Aggression and Tantrum Behavior
by Hunter Manasco (Author)


Children with ASD are often confused by our world of rules and consequences, including how their behavior impacts another person or situation. The result is often aggressive behavior. The Way to A, designed for children ages 3 to 9 years old, presents a simple, logical, and systematic strategy that clarifies and sequentially teaches the child how to manage his behavior by engaging in forethought and self-analysis before acting out. What sets this strategy apart is that it then goes on to give the child a personal and concrete incentive to use the alternative behavior. Developed with visual learners in mind, the book offers the ultimate in customization – the laminated pages may be written on and wiped clean as new situations come up. The illustrations are delightful and use the concrete...

© 2014 BrightSurf.com